BACKGROUND AND OBJECTIVE: Previous research found that prenatal cocaine exposure (PCE) may increase children's vulnerability to behavior and cognition problems. Maturational changes in brain and social development make adolescence an ideal time to reexamine associations. The objective was to conduct a systematic review of published studies examining associations between PCE and adolescent development (behavior, cognition/school outcomes, physiologic responses, and brain morphology/functioning). METHODS: Articles were obtained from PubMed, PsycInfo, Web of Science, and CINAHL databases through July 2012 with search terms: prenatal drug, substance, or cocaine exposure; adolescence/adolescent; and in utero substance/drug exposure. Criteria for inclusion were nonexposed comparison group, human adolescents aged 11 to 19, peer-reviewed, English-language, and adolescent outcomes. RESULTS: Twenty-seven studies representing 9 cohorts met the criteria. Four outcome categories were identified: behavior, cognition/school performance, brain structure/function, and physiologic responses. Eleven examined behavior; 7 found small but significant differences favoring nonexposed adolescents, with small effect sizes. Eight examined cognition/school performance; 6 reported significantly lower scores on language and memory tasks among adolescents with PCE, with varying effect sizes varied. Eight examined brain structure/function and reported morphologic differences with few functional differences. Three examined physiologic responses with discordant findings. Most studies controlled for other prenatal exposures, caregiving environment, and violence exposure; few examined mechanisms. CONCLUSIONS: Consistent with findings among younger children, PCE increases the risk for small but significantly less favorable adolescent functioning. Although the clinical importance of differences is often unknown, the caregiving environment and violence exposure pose additional threats. Future research should investigate mechanisms linking PCE with adolescent functioning.
BACKGROUND AND OBJECTIVE: Previous research found that prenatal cocaine exposure (PCE) may increase children's vulnerability to behavior and cognition problems. Maturational changes in brain and social development make adolescence an ideal time to reexamine associations. The objective was to conduct a systematic review of published studies examining associations between PCE and adolescent development (behavior, cognition/school outcomes, physiologic responses, and brain morphology/functioning). METHODS: Articles were obtained from PubMed, PsycInfo, Web of Science, and CINAHL databases through July 2012 with search terms: prenatal drug, substance, or cocaine exposure; adolescence/adolescent; and in utero substance/drug exposure. Criteria for inclusion were nonexposed comparison group, human adolescents aged 11 to 19, peer-reviewed, English-language, and adolescent outcomes. RESULTS: Twenty-seven studies representing 9 cohorts met the criteria. Four outcome categories were identified: behavior, cognition/school performance, brain structure/function, and physiologic responses. Eleven examined behavior; 7 found small but significant differences favoring nonexposed adolescents, with small effect sizes. Eight examined cognition/school performance; 6 reported significantly lower scores on language and memory tasks among adolescents with PCE, with varying effect sizes varied. Eight examined brain structure/function and reported morphologic differences with few functional differences. Three examined physiologic responses with discordant findings. Most studies controlled for other prenatal exposures, caregiving environment, and violence exposure; few examined mechanisms. CONCLUSIONS: Consistent with findings among younger children, PCE increases the risk for small but significantly less favorable adolescent functioning. Although the clinical importance of differences is often unknown, the caregiving environment and violence exposure pose additional threats. Future research should investigate mechanisms linking PCE with adolescent functioning.
Authors: Zhihao Li; Priya Santhanam; Claire D Coles; Mary Ellen Lynch; Stephan Hamann; Scott Peltier; Xiaoping Hu Journal: Hum Brain Mapp Date: 2011-05 Impact factor: 5.038
Authors: Toni M Whitaker; Henrietta S Bada; Carla M Bann; Seetha Shankaran; Linda LaGasse; Barry M Lester; Charles R Bauer; Jane Hammond; Rosemary Higgins Journal: J Dev Behav Pediatr Date: 2011-04 Impact factor: 2.225
Authors: Ruth Rose-Jacobs; Shayna Soenksen; Danielle P Appugliese; Howard J Cabral; Mark A Richardson; Marjorie Beeghly; Timothy C Heeren; Deborah A Frank Journal: Neurotoxicol Teratol Date: 2011-03-01 Impact factor: 3.763
Authors: Emmalee S Bandstra; Connie E Morrow; Veronica H Accornero; Elana Mansoor; Lihua Xue; James C Anthony Journal: Neurotoxicol Teratol Date: 2011 Jan-Feb Impact factor: 3.763
Authors: M K Greenwald; L M Chiodo; J H Hannigan; R J Sokol; J Janisse; V Delaney-Black Journal: Neurotoxicol Teratol Date: 2010-06-30 Impact factor: 3.763
Authors: Ti-Fei Yuan; Ang Li; Xin Sun; Huan Ouyang; Carlos Campos; Nuno B F Rocha; Oscar Arias-Carrión; Sergio Machado; Gonglin Hou; Kwok Fai So Journal: Mol Neurobiol Date: 2015-11-16 Impact factor: 5.590
Authors: Gale A Richardson; Natacha M De Genna; Lidush Goldschmidt; Cynthia Larkby; John E Donovan Journal: Drug Alcohol Depend Date: 2018-11-24 Impact factor: 4.492
Authors: Yan Wang; Stacy Buckingham-Howes; Prasanna Nair; Shijun Zhu; Laurence S Magder; Maureen M Black Journal: J Adolesc Health Date: 2014-04-24 Impact factor: 5.012
Authors: Sarah W Yip; Elise B Potenza; Iris M Balodis; Cheryl M Lacadie; Rajita Sinha; Linda C Mayes; Marc N Potenza Journal: Neuropsychopharmacology Date: 2014-06-06 Impact factor: 7.853
Authors: Stacy Buckingham-Howes; Samantha P Bento; Laura A Scaletti; James I Koenig; Douglas A Granger; Maureen M Black Journal: Dev Neurosci Date: 2014-05-08 Impact factor: 2.984